In the case of celastrol, this pentacyclic triterpene exerts an anti-obesity action by suppressing GAL-induced fat intake and by activating the PGC-1α/glucose transporter 4 axis-mediated glucose consumption. The gene discussed is GAL; the disease is obesity due to melanocortin 4 receptor deficiency.